Ding, W., et al., Spinal Cord Injury: The Global Incidence, Prevalence, and Disability From the Global Burden of Disease Study 2019. Spine, 2022. 47(21): p. 1532-1540.

Jorge, A., et al., Current agents and related therapeutic targets for inflammation after acute traumatic spinal cord injury. World Neurosurgery, 2019. 132: p. 138-147.

Hagen, E.M., Acute complications of spinal cord injuries. World journal of orthopedics, 2015. 6(1): p. 17.

Sezer, N., S. Akkuş, and F.G. Uğurlu, Chronic complications of spinal cord injury. World journal of orthopedics, 2015. 6(1): p. 24.

Zrzavy, T., et al., Acute and non-resolving inflammation associate with oxidative injury after human spinal cord injury. Brain, 2021. 144(1): p. 144-161.

Sivandzade, F. and L. Cucullo, Regenerative stem cell therapy for neurodegenerative diseases: An overview. International Journal of Molecular Sciences, 2021. 22(4): p. 2153.

Vissers, C., G.-l. Ming, and H. Song, Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders. Advanced drug delivery reviews, 2019. 148: p. 239-251.

Lin, L. and L. Du, The role of secreted factors in stem cells-mediated immune regulation. Cellular Immunology, 2018. 326: p. 24-32.

Huang, J., et al., Cell-free exosome-laden scaffolds for tissue repair. Nanoscale, 2021. 13(19): p. 8740-8750.

Fang, Y., et al., Adipose-derived mesenchymal stem cell exosomes: a novel pathway for tissues repair. Cell and Tissue Banking, 2019. 20(2): p. 153-161.

Kim, Y.G., J. Choi, and K. Kim, Mesenchymal Stem Cell‐Derived Exosomes for Effective Cartilage Tissue Repair and Treatment of Osteoarthritis. Biotechnology Journal, 2020. 15(12): p. 2000082.

Zhao, G., et al., Progress of mesenchymal stem cell-derived exosomes in tissue repair. Current Pharmaceutical Design, 2020. 26(17): p. 2022-2037.

Gurung, S., et al., The exosome journey: From biogenesis to uptake and intracellular signalling. Cell Communication and Signaling, 2021. 19(1): p. 1-19.

Harding, C., J. Heuser, and P. Stahl, Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. The Journal of cell biology, 1983. 97(2): p. 329-339.

Burtenshaw, D., et al., Exosomal Composition, Biogenesis and Profiling Using Point-of-Care Diagnostics-Implications for Cardiovascular Disease. Frontiers in cell and developmental biology, 2022: p. 1072.

Xunian, Z. and R. Kalluri, Biology and therapeutic potential of mesenchymal stem cell‐derived exosomes. Cancer Science, 2020. 111(9): p. 3100-3110.

Ke, W. and K.A. Afonin, Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs). Advanced Drug Delivery Reviews, 2021. 176: p. 113835.

Tang, Y., Y. Zhou, and H.-J. Li, Advances in mesenchymal stem cell exosomes: a review. Stem cell research & therapy, 2021. 12(1): p. 1-12.

Nikfarjam, S., et al., Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine. Journal of Translational Medicine, 2020. 18(1): p. 1-21.

Yu, B., X. Zhang, and X. Li, Exosomes derived from mesenchymal stem cells. Int J Mol Sci, 2014. 15(3): p. 4142-57.

Narang, P., M. Shah, and V. Beljanski, Exosomal RNAs in diagnosis and therapies. Non-coding RNA Research, 2022. 7(1): p. 7-15.

Wei, W., et al., Mesenchymal stem cell–derived exosomes: a promising biological tool in nanomedicine. Frontiers in pharmacology, 2021. 11: p. 590470.

Petrenko, Y., et al., A comparative analysis of multipotent mesenchymal stromal cells derived from different sources, with a focus on neuroregenerative potential. Scientific reports, 2020. 10(1): p. 1-15.

Campagnoli, C., et al., Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood, 2001. 98(8): p. 2396-402.

Meng, X., et al., Endometrial regenerative cells: a novel stem cell population. Journal of translational medicine, 2007. 5(1): p. 1-10.

Dominici, M., et al., Heterogeneity of multipotent mesenchymal stromal cells: from stromal cells to stem cells and vice versa. Transplantation, 2009. 87(9S): p. S36-S42.

Mizukami, A. and K. Swiech, Mesenchymal Stromal Cells: From Discovery to Manufacturing and Commercialization. Stem Cells International, 2018. 2018: p. 4083921.

Pittenger, M.F., et al., Mesenchymal stem cell perspective: cell biology to clinical progress. npj Regenerative Medicine, 2019. 4(1): p. 22.

Chen, Y., et al., Mesenchymal stem cells: A promising candidate in regenerative medicine. The International Journal of Biochemistry & Cell Biology, 2008. 40(5): p. 815-820.

Tang, Y., Y. Zhou, and H.-J. Li, Advances in mesenchymal stem cell exosomes: a review. Stem Cell Research & Therapy, 2021. 12(1): p. 71.

Ren, Z., et al., Mesenchymal stem cell-derived exosomes: hope for spinal cord injury repair. Stem cells and development, 2020. 29(23): p. 1467-1478.

Liu, W.-z., et al., Mesenchymal stem cell-derived exosomes: therapeutic opportunities and challenges for spinal cord injury. Stem Cell Research & Therapy, 2021. 12(1): p. 1-15.

Han, M., et al., Three-dimensional-cultured MSC-derived exosome-hydrogel hybrid microneedle array patch for spinal cord repair. Nano Letters, 2022. 22(15): p. 6391-6401.

Shang, Z., et al., Clinical translation of stem cell therapy for spinal cord injury still premature: results from a single-arm meta-analysis based on 62 clinical trials. BMC medicine, 2022. 20(1): p. 1-19.

Shang, Z., et al., Stem cell-derived exosomes for traumatic spinal cord injury: a systematic review and network meta-analysis based on a rat model. Cytotherapy, 2024. 26(1): p. 1-10.

Yi, H. and Y. Wang, A meta-analysis of exosome in the treatment of spinal cord injury. Open Med (Wars), 2021. 16(1): p. 1043-1060.

Zhang, C., et al., Therapeutic Effect of Exosomes Derived From Stem Cells in Spinal Cord Injury: A Systematic Review Based on Animal Studies. Front Neurol, 2022. 13: p. 847444.

Moher, D., et al., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine, 2009. 151(4): p. 264-269.

Hooijmans, C.R., et al., SYRCLE’s risk of bias tool for animal studies. 2014. 14: p. 1-9.

Doleman, B., et al., Funnel plots may show asymmetry in the absence of publication bias with continuous outcomes dependent on baseline risk: presentation of a new publication bias test. 2020. 11(4): p. 522-534.

Tran, A.P., P.M. Warren, and J. Silver, The Biology of Regeneration Failure and Success After Spinal Cord Injury. Physiol Rev, 2018. 98(2): p. 881-917.

Garcia, E., et al., Cytokine and Growth Factor Activation In Vivo and In Vitro after Spinal Cord Injury. Mediators Inflamm, 2016. 2016: p. 9476020.

Cofano, F., et al., Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy. Int J Mol Sci, 2019. 20(11).

Wang, L., et al., Mesenchymal Stem Cell-Derived Exosomes Reduce A1 Astrocytes via Downregulation of Phosphorylated NFκB P65 Subunit in Spinal Cord Injury. Cell Physiol Biochem, 2018. 50(4): p. 1535-1559.

Huang, J.H., et al., Systemic Administration of Exosomes Released from Mesenchymal Stromal Cells Attenuates Apoptosis, Inflammation, and Promotes Angiogenesis after Spinal Cord Injury in Rats. J Neurotrauma, 2017. 34(24): p. 3388-3396.

Jia, Y., et al., Exosomes secreted from sonic hedgehog-modified bone mesenchymal stem cells facilitate the repair of rat spinal cord injuries. Acta Neurochir (Wien), 2021. 163(8): p. 2297-2306.

Zhang, Y., et al., Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J Neurosurg, 2015. 122(4): p. 856-67.

Fauré, J., et al., Exosomes are released by cultured cortical neurones. Mol Cell Neurosci, 2006. 31(4): p. 642-8.

Simpson, R.J., S.S. Jensen, and J.W. Lim, Proteomic profiling of exosomes: current perspectives. Proteomics, 2008. 8(19): p. 4083-99.

Herberts, C.A., M.S. Kwa, and H.P. Hermsen, Risk factors in the development of stem cell therapy. J Transl Med, 2011. 9: p. 29.

Ning, B., et al., microRNAs in spinal cord injury: potential roles and therapeutic implications. Int J Biol Sci, 2014. 10(9): p. 997-1006.

Liu, N.K., et al., Altered microRNA expression following traumatic spinal cord injury. Exp Neurol, 2009. 219(2): p. 424-9.

Esmailzadeh, S., et al., Regulatory roles of micro-RNAs in T cell autoimmunity. Immunol Invest, 2017. 46(8): p. 864-879.

Chang, Q., et al., Bone marrow mesenchymal stem cell-derived exosomal microRNA-125a promotes M2 macrophage polarization in spinal cord injury by downregulating IRF5. Brain Res Bull, 2021. 170: p. 199-210.

Liu, W., et al., Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization. J Neuroinflammation, 2020. 17(1): p. 47.

de Rivero Vaccari, J.P., et al., Exosome-mediated inflammasome signaling after central nervous system injury. J Neurochem, 2016. 136 Suppl 1(0 1): p. 39-48.

Huang, J.H., et al., Extracellular Vesicles Derived from Epidural Fat-Mesenchymal Stem Cells Attenuate NLRP3 Inflammasome Activation and Improve Functional Recovery After Spinal Cord Injury. Neurochem Res, 2020. 45(4): p. 760-771.

Noori, L., et al., Intrathecal administration of the extracellular vesicles derived from human Wharton's jelly stem cells inhibit inflammation and attenuate the activity of inflammasome complexes after spinal cord injury in rats. Neurosci Res, 2021. 170: p. 87-98.

Jiang, Z. and J. Zhang, Mesenchymal stem cell-derived exosomes containing miR-145-5p reduce inflammation in spinal cord injury by regulating the TLR4/NF-κB signaling pathway. Cell Cycle, 2021. 20(10): p. 993-1009.

Nie, H. and Z. Jiang, Bone mesenchymal stem cell-derived extracellular vesicles deliver microRNA-23b to alleviate spinal cord injury by targeting toll-like receptor TLR4 and inhibiting NF-κB pathway activation. Bioengineered, 2021. 12(1): p. 8157-8172.

Zhang, M., et al., Exosomes with high level of miR-181c from bone marrow-derived mesenchymal stem cells inhibit inflammation and apoptosis to alleviate spinal cord injury. J Mol Histol, 2021. 52(2): p. 301-311.

Zhao, C., et al., Exosomes Derived From Bone Marrow Mesenchymal Stem Cells Inhibit Complement Activation In Rats With Spinal Cord Injury. Drug Des Devel Ther, 2019. 13: p. 3693-3704.

Lu, Y., et al., Bone Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Recovery Following Spinal Cord Injury via Improvement of the Integrity of the Blood-Spinal Cord Barrier. Front Neurosci, 2019. 13: p. 209.

Romanelli, P., et al., Extracellular Vesicles Can Deliver Anti-inflammatory and Anti-scarring Activities of Mesenchymal Stromal Cells After Spinal Cord Injury. Front Neurol, 2019. 10: p. 1225.

Xu, G., et al., miR-21 and miR-19b delivered by hMSC-derived EVs regulate the apoptosis and differentiation of neurons in patients with spinal cord injury. J Cell Physiol, 2019. 234(7): p. 10205-10217.

Drommelschmidt, K., et al., Mesenchymal stem cell-derived extracellular vesicles ameliorate inflammation-induced preterm brain injury. Brain Behav Immun, 2017. 60: p. 220-232.

Huang, W., et al., Paracrine Factors Secreted by MSCs Promote Astrocyte Survival Associated With GFAP Downregulation After Ischemic Stroke via p38 MAPK and JNK. J Cell Physiol, 2015. 230(10): p. 2461-75.

Neal, M., et al., Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes. Glia, 2018. 66(10): p. 2137-2157.

Zhai, X., et al., Extracellular vesicles derived from CD73 modified human umbilical cord mesenchymal stem cells ameliorate inflammation after spinal cord injury. Journal of Nanobiotechnology, 2021. 19(1): p. 274.

Liu, W., et al., Exosomes Derived from Bone Mesenchymal Stem Cells Repair Traumatic Spinal Cord Injury by Suppressing the Activation of A1 Neurotoxic Reactive Astrocytes. J Neurotrauma, 2019. 36(3): p. 469-484.

Wang, T., X. Fang, and Z.S. Yin, Endothelial progenitor cell-conditioned medium promotes angiogenesis and is neuroprotective after spinal cord injury. Neural Regen Res, 2018. 13(5): p. 887-895.

Kho, A.R., et al., Administration of placenta-derived mesenchymal stem cells counteracts a delayed anergic state following a transient induction of endogenous neurogenesis activity after global cerebral ischemia. Brain Res, 2018. 1689: p. 63-74.

Chen, H.J., et al., Human placenta-derived adherent cells improve cardiac performance in mice with chronic heart failure. Stem Cells Transl Med, 2015. 4(3): p. 269-75.

Zhang, C., et al., Exosomes derived from human placenta-derived mesenchymal stem cells improve neurologic function by promoting angiogenesis after spinal cord injury. Neurosci Lett, 2020. 739: p. 135399.

Fan, L., et al., Bone marrow mesenchymal stem cells-derived exosomes reduce apoptosis and inflammatory response during spinal cord injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway. Hum Exp Toxicol, 2021. 40(10): p. 1612-1623.

Ji, W., et al., miR-21 deficiency contributes to the impaired protective effects of obese rat mesenchymal stem cell-derived exosomes against spinal cord injury. Biochimie, 2019. 167: p. 171-178.

Kang, J., et al., MiR-21 derived from the exosomes of MSCs regulates the death and differentiation of neurons in patients with spinal cord injury. Gene Ther, 2019. 26(12): p. 491-503.

Zhou, X., et al., Mesenchymal stem cell derived EVs mediate neuroprotection after spinal cord injury in rats via the microRNA-21-5p/FasL gene axis. Biomed Pharmacother, 2019. 115: p. 108818.

Strand, N.S., et al., Wnt/β-catenin signaling promotes regeneration after adult zebrafish spinal cord injury. Biochem Biophys Res Commun, 2016. 477(4): p. 952-956.

Lambert, C., P. Cisternas, and N.C. Inestrosa, Role of Wnt Signaling in Central Nervous System Injury. Mol Neurobiol, 2016. 53(4): p. 2297-311.

Li, C., et al., Exosomes from Bone Marrow Mesenchymal Stem Cells Inhibit Neuronal Apoptosis and Promote Motor Function Recovery via the Wnt/β-catenin Signaling Pathway. Cell Transplant, 2019. 28(11): p. 1373-1383.

Huang, W., et al., Rat Bone Mesenchymal Stem Cell-Derived Exosomes Loaded with miR-494 Promoting Neurofilament Regeneration and Behavioral Function Recovery after Spinal Cord Injury. Oxid Med Cell Longev, 2021. 2021: p. 1634917.

Huang, W., et al., SiRNA in MSC-derived exosomes silences CTGF gene for locomotor recovery in spinal cord injury rats. Stem Cell Res Ther, 2021. 12(1): p. 334.

Li, C., et al., Exosomes derived from miR-544-modified mesenchymal stem cells promote recovery after spinal cord injury. Arch Physiol Biochem, 2020. 126(4): p. 369-375.

Shao, M., et al., Exosomes from Long Noncoding RNA-Gm37494-ADSCs Repair Spinal Cord Injury via Shifting Microglial M1/M2 Polarization. Inflammation, 2020. 43(4): p. 1536-1547.

Ruppert, K.A., et al., Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Modify Microglial Response and Improve Clinical Outcomes in Experimental Spinal Cord Injury. Sci Rep, 2018. 8(1): p. 480.

Nakazaki, M., et al., Small extracellular vesicles released by infused mesenchymal stromal cells target M2 macrophages and promote TGF-β upregulation, microvascular stabilization and functional recovery in a rodent model of severe spinal cord injury. J Extracell Vesicles, 2021. 10(11): p. e12137.